BRTX BioRestorative Therapies, Inc.
High-Growth Software
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for high-growth software businesses.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 15%
D- 30
  • 5yr Avg ROIC -720.8%
  • Operating Margin Trend +11854.62 pp/yr

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -907.0%
  • 5yr Share-Count CAGR 86.9%

Growth Quality

Weight: 35%
A 88
  • 5yr Revenue CAGR 36.1%
  • Revenue-Growth Years (5) 3/5

Cash Generation

Weight: 20%
F 0
  • 5yr FCF Margin -4449.4%
  • 5yr FCF/NI Conversion 0.00x

Balance Sheet

Weight: 10%
D- 30
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score -69.32

Stability

Weight: 5%
C- 46
  • Negative-Revenue Years (5) 2/5
  • Piotroski F-Score 3

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Not Followed

Not held by any curated guru.